ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Deere shares rise after upbeat quarter; Wolfspeed drops on wider loss

Deere reported better-than-expected Q3 earnings and sales, lifting shares 5.1% in premarket trading. Wolfspeed fell 10.5% after posting a sharply wider-than-expected quarterly loss.

PA
Priya Anand · Equities & Earnings Desk · 22 Aug 2026 · 02:12 · 2 min read
Share
Deere shares rise after upbeat quarter; Wolfspeed drops on wider loss

U.S. stock futures were little changed on Thursday as a bond rally faded and investors assessed corporate earnings. Dow futures fell 0.2%, S&P 500 futures slipped 0.1%, and Nasdaq 100 futures edged up 0.1%.

Deere shares advanced 5.1% in premarket trading after the agricultural equipment manufacturer reported fiscal third-quarter results that exceeded expectations. Diluted earnings per share reached $5.10, topping estimates of $4.67 to $4.79. Net sales totaled about $11 billion, surpassing forecasts of roughly $10.73 billion to $10.81 billion. Net income attributable to Deere rose to $1.379 billion from $1.289 billion a year earlier.

Wolfspeed shares tumbled 10.5% after the semiconductor company posted a substantially wider-than-expected fiscal fourth-quarter loss. Adjusted loss per share was $2.26, compared with a forecast loss of $0.52. Revenue declined 33% to $149.6 million, well below the consensus of $223.55 million and down 24% year-over-year. TD Cowen maintained its Hold rating on the stock.

Other movers included Advance Auto Parts, which sank 15.9% after its second-quarter results showed headline earnings beat but underlying performance missed. Adjusted diluted earnings were $1.03 per share, exceeding the roughly $0.80 consensus, but $0.31 of that stemmed from one-time tariff refunds. Normalized earnings were closer to $0.72 per share, falling short of core business expectations.

Moderna fell 13% in premarket trading following profit-taking after a record surge the prior session. The decline followed news that its personalized mRNA cancer vaccine, intismeran autogene, met both primary and key secondary endpoints in the Phase 3 INTerpath-001 trial involving more than 1,100 high-risk melanoma patients.

Etsy gained 3.9% after BofA Securities upgraded the stock to Buy from Neutral, raising its price target to $105 from $88. The upgrade cited durable execution under CEO Kruti Patel Goyal’s four strategic growth pillars and noted that the mobile app accounts for 47% of gross merchandise sales.

CrowdStrike shares fell 2.8% after a report that its chief technology officer is leaving to launch an AI-focused cybersecurity fund, signaling a leadership change in a market increasingly shaped by artificial intelligence.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT